VEGFA and meningioma: Preclinical studies have demonstrated that VEGF is important for meningioma growth and proliferation.26,27 Retrospective and small prospective studies have suggested the potential benefit of VEGF pathway inhibitors for meningioma.21–24,28 Studies evaluating VEGF pathway inhibitors in recurrent WHO Grade II/III meningioma patients were reviewed (Table 3).